002044 Stock Overview
Meinian Onehealth Healthcare Holdings Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 002044 from our risk checks.
Meinian Onehealth Healthcare Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.89 |
| 52 Week High | CN¥6.60 |
| 52 Week Low | CN¥3.22 |
| Beta | 0.76 |
| 11 Month Change | 22.86% |
| 3 Month Change | 46.85% |
| 1 Year Change | -21.51% |
| 33 Year Change | -35.49% |
| 5 Year Change | -66.94% |
| Change since IPO | -46.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002044 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 2.7% | -2.0% | -2.1% |
| 1Y | -21.5% | -17.0% | 2.8% |
Return vs Industry: 002044 underperformed the CN Healthcare industry which returned -17% over the past year.
Return vs Market: 002044 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 002044 volatility | |
|---|---|
| 002044 Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 8.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002044 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002044's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 38,147 | Tao Xu | www.health-100.cn |
Meinian Onehealth Healthcare Holdings Co., Ltd. engages in the health examination business. It integrates health consultation, health assessment, and health intervention services.
Meinian Onehealth Healthcare Holdings Co., Ltd. Fundamentals Summary
| 002044 fundamental statistics | |
|---|---|
| Market cap | CN¥19.02b |
| Earnings (TTM) | CN¥307.13m |
| Revenue (TTM) | CN¥10.75b |
61.9x
P/E Ratio1.8x
P/S RatioIs 002044 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002044 income statement (TTM) | |
|---|---|
| Revenue | CN¥10.75b |
| Cost of Revenue | CN¥6.17b |
| Gross Profit | CN¥4.58b |
| Other Expenses | CN¥4.27b |
| Earnings | CN¥307.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.079 |
| Gross Margin | 42.59% |
| Net Profit Margin | 2.86% |
| Debt/Equity Ratio | 46.3% |
How did 002044 perform over the long term?
See historical performance and comparison